{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:47:40Z","timestamp":1784918860970,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clindermatol.2013.05.023","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T13:27:26Z","timestamp":1386422846000},"page":"24-34","source":"Crossref","is-referenced-by-count":49,"title":["Acneiform eruptions"],"prefix":"10.1016","volume":"32","author":[{"given":"Clio","family":"Dessinioti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Katsambas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2013.05.023_bb0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clindermatol.2004.03.011","article-title":"Comedone formation: etiology, clinical presentation and treatment","volume":"22","author":"Cunliffe","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1525-1470.2009.00932.x","article-title":"Clinical and therapeutic approach to childhood acne: an update","volume":"26","author":"Antoniou","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaad.2005.03.011","article-title":"Treatment of perioral dermatitis with topical pimecrolimus","volume":"56","author":"Rodriguez-Martin","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0020","first-page":"413","article-title":"Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin","volume":"46","author":"Smith","year":"1990","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1525-1470.1996.tb01419.x","article-title":"Childhood granulomatous periorificial dermatitis","volume":"13","author":"Knautz","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0030","first-page":"341","article-title":"Particuli\u0113re dermatite periorale infantile: observations sur cinq cas","volume":"77","author":"Gianotti","year":"1970","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2230.1990.tb02063.x","article-title":"FACE-facial Afro-Caribbean childhood eruption","volume":"15","author":"Williams","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0040","first-page":"399","article-title":"Granulomatous periorificial dermatitis","volume":"73","author":"Tarm","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2340\/0001555558433436","article-title":"Micropapular sarcoidal facial eruption in a child: Gianotti-type perioral dermatitis","volume":"58","author":"Georgouras","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0050","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archderm.138.10.1354","article-title":"Extrafacial and generalized granulomatous periorificialdermatitis","volume":"138","author":"Urbatsch","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2230.2002.01019.x","article-title":"Childhood granulomatous periorificial dermatitis in an Asian girl-a variant of sarcoid?","volume":"27","author":"Antony","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0060","first-page":"470","article-title":"Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children?","volume":"19","author":"Misago","year":"2005","journal-title":"JEADV"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archderm.1989.01670150059008","article-title":"Granulomatous perioral dermatitis in children","volume":"125","author":"Frieden","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0070","first-page":"76","article-title":"Granulomatous perioral dermatitis in childhood: eight cases","volume":"12","author":"Andry","year":"1995","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0075","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/archderm.128.10.1396","article-title":"Multiple facial, neck and upper trunk papules in a black child","volume":"128","author":"Hansen","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0080","first-page":"99","article-title":"Rosacea in the pediatric population","volume":"74","author":"Lacz","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaad.2006.05.031","article-title":"Periorificial dermatitis in children and adolescents","volume":"55","author":"Nguyen","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1468-3083.2006.01820.x","article-title":"Granulomatous periorifical dermatitis in an 11-year-old boy: dramatic response to tacrolimus","volume":"21","author":"Hussain","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0095","article-title":"Azelaic acid for childhood periorificial dermatitis in a Greek girl","author":"Antoniou","year":"2008"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0100","first-page":"99","article-title":"Rosacea in the pediatric population","volume":"74","author":"Lacz","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000336797","article-title":"Segmental acne versus mosaic conditions with acne lesions","volume":"224","author":"Torchia","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0110","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archderm.1972.01620150029011","article-title":"Acne cosmetica","volume":"106","author":"Kligman","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0190-9622(84)80050-X","article-title":"Comedogenicity of current therapeutic products, cosmetics and ingredients in the rabbit ear","volume":"10","author":"Fulton","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0120","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archderm.1975.01630160071007","article-title":"Acne mechanica","volume":"111","author":"Mills","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0125","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0190-9622(97)70173-7","article-title":"Prevalence of acne keloidalis nuchae in football players","volume":"37","author":"Dnable","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0130","first-page":"125","article-title":"Acne mechanica in athletes","volume":"50","author":"Basler","year":"1992","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000338694","article-title":"Exogenous inflammatory acne due to combined application of cosmetic and facial rubbing","volume":"224","author":"Seneschal","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0140","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(09)60912-0","article-title":"2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites","volume":"374","author":"Sorg","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/toxsci\/kfr223","article-title":"The cutaneous lesions of dioxin exposure: lessons from the poisoning of Victor Yushchenko","volume":"125","author":"Saurat","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000290672","article-title":"Chloracne: a misnomer and its implications","volume":"221","author":"Saurat","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000017841","article-title":"Acneiform dermatoses. Dermatology","volume":"196","author":"Plewig","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0160","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0165","first-page":"1","article-title":"Rosacea, perioral dermatitis and similar dermatoses, flushing and flushing syndromes","volume":"Vol 3","author":"Berth-Jones","year":"2010"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-3083.2011.04310.x","article-title":"Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link","volume":"26","author":"Forton","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0175","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000317132","article-title":"Management of the cutaneous side effects of therapeuticepidermal growth factor receptor inhibition","volume":"33","author":"Reck","year":"2010","journal-title":"Onkologie"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0180","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2004.04.010","article-title":"Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life","volume":"51","author":"Tan","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0185","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2133.2012.11114.x","article-title":"Positive correlation between serum immune-reactivity to Demodex-associated Bacillus proteins and erythematotelangiectic rosacea","volume":"167","author":"O'Reilly","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0190","first-page":"73","article-title":"The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea","volume":"79","author":"Wolf","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0195","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0200","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","article-title":"Effective and evidence based management strategies for rosacea: summary of a Cochrane systematic review","volume":"165","author":"Van Zuuren","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0205","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2133.2011.10590.x","article-title":"Interventions for 'rosacea","volume":"165","author":"Powell","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment of moderate to severe facial erythema of rosacea: results of two multicenter, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0215","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2008.08496.x","article-title":"Pimecroliums 1% cream for the treatment of steroid-induced rosacea: an 8-week split-case clinical trial","volume":"158","author":"Lee","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0220","first-page":"729","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archderm.140.4.457","article-title":"Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment","volume":"140","author":"Antille","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0230","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jaad.2011.05.037","article-title":"Crusted rosacea-like demodicidosis in an HIV-positive female","volume":"65","author":"Brutti","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2340\/00015555-1200","article-title":"Rosacea-like demodicosis mimicking cutaneous lymphoma","volume":"92","author":"Kito","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0240","first-page":"1927","article-title":"Azelaic acid as a new treatment for perioral dermatitis: results from an open study","volume":"151","author":"Jansen","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2008.03.043","article-title":"A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis","volume":"59","author":"Schwarz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0250","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1468-3083.2007.02191.x","article-title":"Pimecrolimus cream (1%) efficacy in perioral dermatitis: results of a randomized, double-blind vehicle-controlled study in 40 patients","volume":"21","author":"Oppel","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0255","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","first-page":"702","article-title":"Acne vulgaris and acneiform eruptions","author":"Zaenglein","year":"2008"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11588900-000000000-00000","article-title":"Drug-induced acneiform eruption","volume":"12","author":"Du-Thanh","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0265","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/edm.11.70","article-title":"New targeted approaches for the treatment and prevention of nonmelanoma skin cancer","volume":"6","author":"Dessinioti","year":"2011","journal-title":"Exp Rev Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaad.2006.09.005","article-title":"Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management","volume":"56","author":"Hu","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0275","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/annonc\/mdq387","article-title":"Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion","volume":"22","author":"Potthoff","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0280","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2007.12.6987","article-title":"Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab associated acne-like eruptions","volume":"25","author":"Scope","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0285","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0290","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1365-2133.2001.04226.x","article-title":"Cutaneous side effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225","volume":"144","author":"Busam","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0295","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.2004.06026.x","article-title":"Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours","volume":"151","author":"Jacot","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0300","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1600-0625.2008.00715.x","article-title":"A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition","volume":"17","author":"Wollenberg","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0305","first-page":"46","article-title":"Erlotinib-induced florid acneiform rash complicated with impetiginization","volume":"33","author":"Kardaum","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0310","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1468-3083.2009.03490.x","article-title":"Cetuximab-induced cutaneous toxicity","volume":"24","author":"Tomkova","year":"2010","journal-title":"J Eur Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-3083.2012.04546.x","article-title":"Cutaneous side effects of inhibitors of the RAS\/RAF\/MEK\/ERK signaling pathway and their management","volume":"27","author":"Manousaridis","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0320","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/cncr.23621","article-title":"Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB)","volume":"113","author":"Jatoi","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0325","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2007.12.6987","article-title":"Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption","volume":"25","author":"Scope","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0330","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000317132","article-title":"Management of the cutaneous side effects of therapeuticepidermal growth factor receptor inhibition","volume":"33","author":"Reck","year":"2010","journal-title":"Onkologie"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0335","unstructured":"Common Terminology Criteria Adverse Events (CTCAE) version 4.0. Available online at: http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5\u00d711.pdf. Assessed December 20, 2012."},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0340","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archdermatol.2011.3575","article-title":"Cutaneous B-cell neoplasms mimicking granulomatous rosacea or rhinophyma","volume":"148","author":"Barzilai","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0345","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaad.2010.10.036","article-title":"Acneiform presentation of primary cutaneous follicle center lymphoma","volume":"65","author":"Soon","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.05.023_bb0350","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2010.07.035","article-title":"Miliary and agminated-type primary cutaneous follicle center lymphoma: report of 18 cases","volume":"65","author":"Massone","year":"2011","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:12:11Z","timestamp":1716268331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X13000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0738081X13000904"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2013.05.023","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}